A new daily pill for obesity, orforglipron, has shown promising results in a major clinical trial, helping patients lose ...

In a phase 3 trial, the daily GLP-1 pill has shown "meaningful weight loss" and similar side effects to injectable GLP-1 drugs like Ozempic, Eli Lilly has said., Health, Times Now ...

Eli Lilly, the Indiana Fever and the YMCA of Greater Indianapolis have announced a collaborative partnership designed to ...

Health-care companies ticked up as traders rotated back into the beaten-down sector. Shares of Eli Lilly and UnitedHealth Group, among other companies that have recently seen major downdrafts in their ...

The up to $100 million in state tax incentives for a $3 billion Eli Lilly expansion in Kenosha County isn’t the only tax incentive for the project. The expansion is also part of a tax increment ...

Shares of Eli Lilly (NYSE: LLY), the pharmaceuticals giant and maker of the Mounjaro and Zepbound weight loss drugs, saw its ...

There are a number of emerging therapies in development for lowering lipoprotein(a), and later-stage trials are underway.Interest continues to grow in lipoprotein(a), commonly known as Lp(a), both as ...

A new study by Boston researchers indicates women who have been stalked or obtained a restraining order have an increased ...

Novo Nordisk A/S is suffering from headwinds in its core anti-obesity medications market. Click here to find out why NVO ...

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

The initiative, titled 'The Court Is Hers,' eliminates registration fees for girls basketball programs at the YMCA.

Eli Lilly and Company (NYSE: LLY) is one of the top most profitable NYSE stocks to buy now. On August 7, Leerink downgraded ...